COVID-19 Evidence Accelerator Aims to Facilitate Collaboration

The Reagan-Udall Foundation, in partnership with Friends of Cancer Research, recently launched a new initiative for the FDA aimed at streamlining collaboration regarding COVID-19 treatments.

“The Accelerator will bring together the country’s leading experts in health data aggregation and analytics in a unified effort to share insights, compare results, and answer key questions about COVID-19 treatment and response as quickly as possible,” Friends of Cancer Research says.

To read more, click here.